» Articles » PMID: 35632685

Can Virus-like Particles Be Used As Synergistic Agent in Pest Management?

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2022 May 28
PMID 35632685
Authors
Affiliations
Soon will be listed here.
Abstract

Among novel strategies proposed in pest management, synergistic agents are used to improve insecticide efficacy through an elevation of intracellular calcium concentration that activates the calcium-dependent intracellular pathway. This leads to a changed target site conformation and to increased sensitivity to insecticides while reducing their concentrations. Because virus-like particles (VLPs) increase the intracellular calcium concentration, they can be used as a synergistic agent to synergize the effect of insecticides. VLPs are self-assembled viral protein complexes, and by contrast to entomopathogen viruses, they are devoid of genetic material, which makes them non-infectious and safer than viruses. Although VLPs are well-known to be used in human health, we propose in this study the development of a promising strategy based on the use of VLPs as synergistic agents in pest management. This will lead to increased insecticides efficacy while reducing their concentrations.

Citing Articles

The Role of Plant Virus-like Particles in Advanced Drug Delivery and Vaccine Development: Structural Attributes and Application Potential.

Peralta-Cuevas E, Garcia-Atutxa I, Huerta-Saquero A, Villanueva-Flores F Viruses. 2025; 17(2).

PMID: 40006903 PMC: 11861432. DOI: 10.3390/v17020148.


Highly stable L-BC capsids with versatile packing potential.

Celitan E, Staneviciene R, Serviene E, Serva S Front Bioeng Biotechnol. 2024; 12:1456453.

PMID: 39386045 PMC: 11461329. DOI: 10.3389/fbioe.2024.1456453.

References
1.
Hill B, Zak A, Khera E, Wen F . Engineering Virus-like Particles for Antigen and Drug Delivery. Curr Protein Pept Sci. 2016; 19(1):112-127. DOI: 10.2174/1389203718666161122113041. View

2.
Mazalovska M, Kouokam J . Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus. Viruses. 2020; 12(8). PMC: 7472025. DOI: 10.3390/v12080826. View

3.
. Hepatitis B vaccines: WHO position paper--recommendations. Vaccine. 2009; 28(3):589-90. DOI: 10.1016/j.vaccine.2009.10.110. View

4.
Jarvis D, Kawar Z, Hollister J . Engineering N-glycosylation pathways in the baculovirus-insect cell system. Curr Opin Biotechnol. 1998; 9(5):528-33. DOI: 10.1016/s0958-1669(98)80041-4. View

5.
Yang L, Song Y, Li X, Huang X, Liu J, Ding H . HIV-1 virus-like particles produced by stably transfected Drosophila S2 cells: a desirable vaccine component. J Virol. 2012; 86(14):7662-76. PMC: 3416305. DOI: 10.1128/JVI.07164-11. View